Pubdate: Thu, 21 Nov 2002
Source: New Scientist (UK)
Copyright: New Scientist, RBI Limited 2002
Contact:  http://www.newscientist.com/
Details: http://www.mapinc.org/media/294
Author: Emma Young
Note: This item appeared at the source's web site, Newscientist.com, 
reporting on studies published in the source's print edition.
Bookmark: http://www.mapinc.org/pot.htm (Cannabis)

CANNABIS LINK TO MENTAL ILLNESS STRENGTHENED

The link between regular cannabis use and later depression and 
schizophrenia has been significantly strengthened by three new studies.

The studies provide "little support" for an alternative explanation - that 
people with mental illnesses self-medicate with marijuana - according to 
Joseph Rey and Christopher Tennant of the University of Sydney, who have 
written an editorial on the papers in the British Medical Journal.

One of the key conclusions of the research is that people who start smoking 
cannabis as adolescents are at the greatest risk of later developing mental 
health problems. Another team calculates that eliminating cannabis use in 
the UK population could reduce cases of schizophrenia by 13 per cent.

Until now, say Rey and Tennant, there was "a dearth of reliable evidence" 
to support the idea that cannabis use could cause schizophrenia or 
depression. That lack of good evidence "has handicapped the development of 
rational public health policies," according to one of the research groups, 
led by George Patton at the Murdoch Children's Research Institute in 
Melbourne, Australia.

The works also highlights potential risks associated with using cannabis as 
a medicine to ease the symptoms of muscular sclerosis, for example.

Pharmacological effect

Patton's team followed over 1600 Australian school pupils aged 14 to 15 for 
seven years. Daily cannabis use was associated with a five-fold increased 
risk of depression at the age of 20. Weekly use was linked to a two-fold 
increase. The regular users were no more likely to have suffered from 
depression or anxiety at the start of the study.

The reason for the link is unclear. Social consequences of frequent 
cannabis use include educational failure and unemployment, which could 
increase the risk of depression. "However, because the risk seems confined 
largely to daily users, the question about a direct pharmacological effect 
remains," says Patton.

In separate research, a team led by Stanley Zammit at the University of 
Cardiff, UK, evaluated data on over 50,000 men who had been Swedish 
military conscripts in 1969 and 1970. This group represents 97 per cent of 
men aged 18 to 20 in the population at that time.

The new analysis revealed a dose-dependant relationship between the 
frequency of cannabis use and schizophrenia. This held true in men with no 
psychotic symptoms before they started using cannabis, suggesting they were 
not self-medicating.

Genetic Factors

Finally, researchers led by Terrie Moffitt at King's College London, UK, 
analysed comprehensive data on over 1000 people born in Dunedin, New 
Zealand in 1972 and 1973.

They found that people who used cannabis by age 15 were four times as 
likely to have a diagnosis of schizophreniform disorder (a milder version 
of schizophrenia) at age 26 than non-users.

But when the number of psychotic symptoms at age 11 was controlled for, 
this increased risk dropped to become non-significant. This suggests that 
people already at greater risk of later developing mental health problems 
are also more likely to smoke cannabis.

The total number of high quality studies on cannabis use and mental health 
disorders remains small, stress Rey and Tennant. And it is still not clear 
whether cannabis can cause these conditions in people not predisposed by 
genetic factors, for example, to develop them.

"The overall weight of evidence is that occasional use of cannabis has few 
harmful effects overall," Zammit's team writes. "Nevertheless, our results 
indicate a potentially serious risk to the mental health of people who use 
cannabis. Such risks need to be considered in the current move to 
liberalise and possibly legalise the use of cannabis in the UK and other 
countries."

Journal references: British Medical Journal (vol 325, p1195, p1199, p1212, 
p1183)
- ---
MAP posted-by: Jackl